Remdesivir Data from NIAID Trial Published

]]>(MedPage Today) -- Peer-reviewed findings were published late Friday from one of the key trials of remdesivir, perhaps the most promising antiviral agent for COVID-19, confirming and extending topline results announced a month ago via press release...